These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24693773)

  • 21. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
    Eriksson BI; Kakkar AK; Turpie AG; Gent M; Bandel TJ; Homering M; Misselwitz F; Lassen MR
    J Bone Joint Surg Br; 2009 May; 91(5):636-44. PubMed ID: 19407299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
    Özler T; Uluçay Ç; Önal A; Altıntaş F
    Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty.
    Russell RD; Huo MH
    J Arthroplasty; 2013 Oct; 28(9):1477-81. PubMed ID: 23540535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivaroxaban versus enoxaparin after total knee arthroplasty.
    Raju NC; Dimmitt S; Eikelboom JW
    Lancet; 2009 Aug; 374(9691):681; author reply 683. PubMed ID: 19716954
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin).
    Rosencher N; Llau JV; Mueck W; Loewe A; Berkowitz SD; Homering M
    Acta Anaesthesiol Scand; 2013 May; 57(5):565-72. PubMed ID: 23336294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban versus enoxaparin after total knee arthroplasty.
    Stief T
    Lancet; 2009 Aug; 374(9691):681; author reply 683. PubMed ID: 19716952
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study.
    Xie J; Ma J; Huang Q; Yue C; Pei F
    Med Sci Monit; 2017 Feb; 23():704-711. PubMed ID: 28174415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
    Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
    Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P;
    Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
    Nieto JA; Espada NG; Merino RG; González TC
    Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of hemostatic effect and safety in primary unilateral total hip arthroplasty receiving different anticoagulants after anti-fibrinolysis with tranexamic acid].
    Deng Z; Sheng P; Xu D; Fu M; He A; Liao W; Kang Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Dec; 34(12):1561-1567. PubMed ID: 33319536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
    Rath NK; Goodson MW; White SP; Forster MC
    Knee; 2013 Dec; 20(6):397-400. PubMed ID: 23566737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
    Borris LC
    Arch Orthop Trauma Surg; 2010 May; 130(5):583-9. PubMed ID: 19565250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
    Alves C; Batel-Marques F; Macedo AF
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):266-76. PubMed ID: 22134134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.